Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Spanish paediatric cancer Dx (diagnosis) needs:

This article was originally published in Clinica

Executive Summary

The early confirmatory diagnosis of cancer in children has become a top priority - as well as a leading challenge - in Spain, according to the national paediatrics association (AEP). Some 900 new cases per million children (aged 0-15 years) are recorded annually, of which 40% occur in the 1-4-year age range, and 20% in those aged 5-9. Speaking at the association's annual conference, held last week in Barcelona, Dr Josep Sanchez de Toledo, of the city's Val d'Hebron hospital, noted the difficulty in differentiating the symptoms of common, far less serious conditions - headaches, bone/joint pain, abdominal swelling or a cough - from the first signs of cancer. "Much progress has been made, but the prevalence rates make it necessary to intensify early diagnosis [efforts]," he said. Meanwhile, survival rates have improved by around 20% over the last two decades, to 76%, the AEP says, citing data from the national paediatric cancer register.

You may also be interested in...

Butterfly Network’s CEO Sees Blank Check Deal As Path To ‘Democratize’ Portable Imaging Platform

Butterfly Network chose SPAC route with Longview Acquisition Corp. to scale its business and expand into the home market in 2021.

Regenerative Medicine Comes Of Age – In The Age Of COVID-19

Regulatory review resource-intensive cell and gene therapy licensing applications are rolling toward US FDA along expedited pathways, while complete response letters and missed goal dates start to stack up under pandemic inspection constraints.

With Warp Speed Decisions Already Made, Transitioning To Biden Admin Should Be No Trouble, Slaoui Says

As vaccines near availability, Moncef Slaoui says his full-time role at OWS may be ending. He has not met with the Biden Transition team, but notes that other Warp Speed officials have.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts